26 Feb FDA Says Johnson & Johnson COVID-19 Vaccine Is Safe and Effective
The U.S. Food and Drug Administration (FDA) recently released an analysis that found that Johnson & Johnson’s COVID-19 vaccine is safe and effective.
According to the FDA, the vaccine meets requirements for an Emergency Use Authorization (EUA). The vaccine, developed by Janssen Biotech Inc., a subsidiary of Johnson & Johnson, has been found to have 72% efficacy in the United States, while proving less effective in Latin America and South Africa, where a highly contagious variant is behind most new cases. The vaccine has also demonstrated 86% efficacy against severe forms of COVID-19 in the United States, with 82% against severe outcomes in South Africa.12 Feb CDC Guidance for Workplace COVID-19 Vaccination Programs
Making COVID-19 vaccination part of your workplace wellness program may offer benefits to you and your employees.
To aid in keeping their workplace healthy, employers can consider offering free, onsite COVID-19 vaccinations at work locations. This HR Insights article provides an overview of guidance from the Centers for Disease Control and Prevention (CDC) for workplace vaccination programs. As of this writing, vaccine programs are not yet available to many employers, depending on the type of organization and guidance from local officials.05 Feb COVID-19 Vaccination FAQs
The Centers for Disease Control and Prevention (CDC) has prepared a list of FAQs to help educate the public on various aspects of COVID-19 vaccination. This article features some of these FAQs.
02 Dec How To Encourage Employees to Use Telehealth Services
The COVID-19 pandemic has proven just how convenient telehealth services can be.
According to a survey from FAIR Health, there was a 4,347% increase nationally in telehealth utilization from March 2019 to March 2020. In addition, many providers and hospitals are encouraging patients to utilize telehealth services instead of coming to the office or hospital for non-life-threatening care.